Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapyA pooled analysis of two randomized studies

被引：5
|
作者：
Aristotle Bamias
George Basdanis
Ioannis Xanthakis
Nicholas Pavlidis
George Fountzilas
机构：
[1] University of Athens,Dept of Clinical Therapeutics, Medical School
[2] Aristotle University of Thessaloniki,Medical School
[3] Ioannina University,Medical School
来源：
International Journal of Gastrointestinal Cancer | 2005年 / 36卷 / 1期
关键词：
Adjuvant therapy; colorectal cancer; prognostic factors; 5-FU;
D O I：
10.1385/IJGC:36:1:029
中图分类号：
学科分类号：
摘要：
Background. Although the TNM system is useful in predicting survival in resected colorectal cancer, heterogeneity within the same stages regarding prognosis exists. We are presenting a pooled analysis of prognostic factors from two randomized studies of adjuvant treatment conducted by the Hellenic Cooperative Oncology Group.
引用
收藏
页码：29 / 38
页数：9
相关论文
共 50 条
  • [1] Prognostic Factors in Patients with Colorectal Cancer Receiving Adjuvant Chemotherapy or Chemoradiotherapy
    Banzias, Aristotle
    Basdanis, George
    Xanthakis, Ioannis
    Pavlidis, Nicholas
    Fountzilas, George
    JOURNAL OF GASTROINTESTINAL CANCER, 2005, 36 (01) : 29 - 38
  • [2] Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
    Mitry, Emmanuel
    Fields, Anthony L. A.
    Bleiberg, Harry
    Labianca, Roberto
    Portier, Guillaume
    Tu, Dongsheng
    Nitti, Donato
    Torri, Valter
    Elias, Dominique
    O'Callaghan, Chris
    Langer, Bernard
    Martignoni, Giancarlo
    Bouche, Olivier
    Lazorthes, Franck
    Van Cutsem, Eric
    Bedenne, Laurent
    Moore, Malcolm J.
    Rougier, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4906 - 4911
  • [3] Prognostic factors in patients with colon cancer receiving adjuvant 5-FU-based chemotherapy: analysis of a randomized trial including 855 patients
    Kornmann, M.
    Sander, S.
    Staib, L.
    Henne-Bruns, D.
    Link, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 175 - 175
  • [4] Prognostic Factors of Locally Advanced Breast Cancer Patients Receiving Neoadjuvant and Adjuvant Chemotherapy
    Akhsan, Alfiyannul
    Aryandono, Teguh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (03) : 759 - 761
  • [5] PLASMA CEA IN PATIENTS WITH COLORECTAL CANCER RECEIVING ADJUVANT CHEMOTHERAPY
    LAWTON, JO
    COOPER, EH
    GILES, GR
    BRITISH JOURNAL OF SURGERY, 1978, 65 (11) : 821 - 821
  • [6] Level of fatigue in colorectal cancer patients (ccp) receiving adjuvant chemotherapy
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Karagiannis, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] BCIRG 001 Molecular Analysis: Prognostic Factors in Node-Positive Breast Cancer Patients Receiving Adjuvant Chemotherapy
    Dumontet, Charles
    Krajewska, Maryla
    Treilleux, Isabelle
    Mackey, John R.
    Martin, Miguel
    Rupin, Mathieu
    Lafanechere, Laurence
    Reed, John C.
    CLINICAL CANCER RESEARCH, 2010, 16 (15) : 3988 - 3997
  • [8] Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy
    Kimura, M.
    Iwai, M.
    Usami, E.
    Teramachi, H.
    Yoshimura, T.
    PHARMAZIE, 2018, 73 (02): : 115 - 119
  • [9] Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy
    Kietpeerakool, Chumnan
    Srisomboon, Jatupol
    Phongsaranantakul, Supareuk
    Khunamornpong, Surapan
    Cheewakriangkrai, Chalong
    Sribanditmongkol, Narisa
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (03) : 806 - 811
  • [10] PROGNOSTIC FACTORS IN NODE-POSITIVE OPERABLE BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
    RAKOWSKY, E
    KLEIN, B
    KAHAN, E
    DERAZNE, E
    LURIE, H
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 21 (02) : 121 - 131
12345